Target led the pack last year in the U.S. when it came to trademark applications. With 525 applications to the United States ...

U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for acute heart failure, this patent would provide protection to ...

Patent deals are getting done. Although the value of the patent deals currently being consummated has not increased in 2025 ...

UPPSALA, SWEDEN / ACCESS Newswire / July 1, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF), today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent protecting and ...

Coffee News is proud to maintain advertising partnerships with many of the world’s leading coffee companies, yet maintains a ...

Moolec Science has obtained a US patent for its Piggy Sooy™ technology, a novel soybean engineered to produce high levels of ...

Patent supports the Company’s broader mission to advance minimally invasive, nerve-focused treatments across high-need ...

Patent lawyers explain why they will be keeping an eye on the implications of a pharma case and on changes at the USPTO in ...

GM has filed to trademark the name Elevera, set for use in a new vehicle seat design or tech. It's currently unclear exactly ...

Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced that the U.S. Patent and Trademark Office has issued a new patent covering its lead investigational therapy, istaroxime, for intravenous ...

A new era of authentic intelligence begins. Landmark Filing Establishes Verifiable Cognitive Architecture Designed for Ethics ...

A patent owner will appeal the acting chief of the US Patent and Trademark Office’s refusal to retroactively apply recent guidance easing administrative judges’ ability to reject validity challenges ...